Garcia-Puig, Juan, Ruilope, Luis M., Luque, Manuel, Fernandez, Jaime, Ortega, Rafael, and Dal-Re, Rafael
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2005.09.010 Byline: Juan Garcia-Puig (a), Luis M. Ruilope (b), Manuel Luque (c), Jaime Fernandez (d), Rafael Ortega (d), Rafael Dal-Re (d) Keywords: Insulin resistance; Hypertension; Type 2 diabetes; Impaired fasting glucose; Impaired glucose tolerance; Left ventricular hypertrophy Abstract: Arterial hypertension is an insulin-resistant condition that has been associated with an increased incidence of diabetes. We assessed the prevalence of glucose abnormalities in a population of patients with essential hypertension. Author Affiliation: (a) Division of Internal Medicine at Hospital Universitario 'La Paz,', Madrid, Spain (b) Hypertension Units at Hospital Universitario 12 de Octubre, Madrid, Spain (c) Hospital Clinico Universitario, Madrid, Spain (d) Medical Department, GlaxoSmithKline, Madrid, Spain. Article History: Received 12 July 2005; Revised 6 September 2005; Accepted 6 September 2005 Article Note: (footnote) GlaxoSmithKline SA, Tres Cantos, Madrid, Spain, sponsored the study. Drs Juan Garcia Puig, Luis M. Ruilope, and Manuel Luque received research grants from Pfizer, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Novartis, Boeghringer, Sanofi-Aventis, and AstraZeneca, and lecture fees from these companies. Drs Jaime Fernandez, Rafael Ortega, and Rafael Dal-Re were employees of GlaxoSmithKline when the study was performed.